Sign Up Now to Download a Free Research Report on
Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts
Having problems viewing PDF files? Protalix BioTherapeutics, Inc.
Protalix BioTherapeutics shares surged 17 percent on a large volume spike of nearly 7 million shares traded Tuesday. The company reported that it has engaged Citigroup to assist in reviewing “a broad array of product partnering, technology sharing and other strategic alternatives.”
Going forward ... (see research report)
Subscribe to News Feeds